Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

The glucocorticoid antagonist RU-486 suppresses HIV infectivity and replication.

Benton TD, Lynch KG, Dubé B, Gettes DR, Tustin NB, Metzger DS, Blume J, Douglas SD, Evans DL.

J Neuropsychiatry Clin Neurosci. 2013 Winter;25(1):51-7. doi: 10.1176/appi.neuropsych.12060147.

PMID:
23487193
2.

Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication.

Benton T, Lynch K, Dubé B, Gettes DR, Tustin NB, Ping Lai J, Metzger DS, Blume J, Douglas SD, Evans DL.

Psychosom Med. 2010 Nov;72(9):925-32. doi: 10.1097/PSY.0b013e3181f883ce. Epub 2010 Oct 14.

3.

Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome.

Evans DL, Lynch KG, Benton T, Dubé B, Gettes DR, Tustin NB, Lai JP, Metzger D, Douglas SD.

Biol Psychiatry. 2008 May 1;63(9):899-905. Epub 2007 Oct 22.

4.

Mifepristone: treatment of Cushing's syndrome.

Sartor O, Cutler GB Jr.

Clin Obstet Gynecol. 1996 Jun;39(2):506-10. Review.

PMID:
8734015
5.

Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder.

Young AH, Gallagher P, Watson S, Del-Estal D, Owen BM, Ferrier IN.

Neuropsychopharmacology. 2004 Aug;29(8):1538-45.

6.

Dendritic cell-mediated HIV-1 infection of T cells demonstrates a direct relationship to plasma viral RNA levels.

Arora R, Bull L, Siwak EB, Thippeshappa R, Arduino RC, Kimata JT.

J Acquir Immune Defic Syndr. 2010 Jun;54(2):115-21. doi: 10.1097/QAI.0b013e3181daaf98.

7.
8.

Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine.

Chiang G, Sassaroli M, Louie M, Chen H, Stecher VJ, Sperber K.

Clin Ther. 1996 Nov-Dec;18(6):1080-92.

PMID:
9001825
9.

CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages.

Moriuchi H, Moriuchi M, Combadiere C, Murphy PM, Fauci AS.

Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15341-5.

10.

Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patients.

Donia M, Anzaldi M, Di Marco R, Libra M, Mangano K, Fagone P, Galvagna S, Di Gregorio P, Nicoletti F.

Int J Mol Med. 2011 Sep;28(3):437-42. doi: 10.3892/ijmm.2011.703. Epub 2011 May 20.

PMID:
21617839
11.

Substance P enhances HIV-1 replication in latently infected human immune cells.

Li Y, Douglas SD, Song L, Sun S, Ho WZ.

J Neuroimmunol. 2001 Dec 3;121(1-2):67-75.

PMID:
11730941
12.

Effects of adjunctive mifepristone (RU-486) administration on neurocognitive function and symptoms in schizophrenia.

Gallagher P, Watson S, Smith MS, Ferrier IN, Young AH.

Biol Psychiatry. 2005 Jan 15;57(2):155-61.

PMID:
15652874
13.

Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection.

Biswas P, Ferrarini M, Mantelli B, Fortis C, Poli G, Lazzarin A, Manfredi AA.

Eur J Immunol. 2003 Jan;33(1):252-63.

15.

Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia.

Gallagher P, Watson S, Elizabeth Dye C, Young AH, Nicol Ferrier I.

J Psychiatr Res. 2008 Oct;42(12):1037-41. doi: 10.1016/j.jpsychires.2007.12.005. Epub 2008 Feb 5.

PMID:
18255098
16.
17.

Neutrophils from human immunodeficiency virus (HIV)-seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis.

Ho JL, He S, Hu A, Geng J, Basile FG, Almeida MG, Saito AY, Laurence J, Johnson WD Jr.

J Exp Med. 1995 Apr 1;181(4):1493-505. Erratum in: J Exp Med 1999 Nov 1;190(9):following 1362.

18.
19.

Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells.

Rabbi MF, Finnegan A, Al-Harthi L, Song S, Roebuck KA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1;19(4):321-31.

PMID:
9833740
20.

The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro.

La Maestra L, Zaninoni A, Marriott JB, Lazzarin A, Dalgleish AG, Barcellini W.

Clin Exp Immunol. 2000 Jan;119(1):123-9.

Items per page

Supplemental Content

Write to the Help Desk